Peter Higgins, MD
Gastroenterology · Ann Arbor, MINPI 1528141439
Payments from drug & device makers
Across 615 payments — averaging $3935.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.5M
- Pfizer$338K
- Takeda Pharmaceuticals U.S.A., Inc.$107K
- Roche Products Limited$87K
- Genentech, Inc.$65K
- Amgen$58K
- plus $260K from 18 others
Across 2 payments — averaging $2149.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$4K
- F. Hoffmann-la Roche AG$178
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 410 | $1,505,421 |
| Pfizer | 18 | $337,782 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $106,661 |
| Roche Products Limited | 45 | $86,850 |
| Genentech, Inc. | 9 | $65,396 |
| Amgen | 5 | $57,814 |
| Eli Lilly | 20 | $57,274 |
| Shire North American Group Inc | 19 | $42,546 |
| Boehringer Ingelheim International GmbH | 1 | $32,131 |
| Boehringer Ingelheim | 2 | $31,125 |
| Janssen Research & Development, LLC | 6 | $28,576 |
| Takeda | 3 | $19,602 |
| Siemens Medical Solutions USA, Inc. | 2 | $10,150 |
| Merck | 9 | $8,925 |
| Johnson & Johnson | 6 | $7,819 |
| Whitehall International Inc | 1 | $5,120 |
| Biofire Diagnostics, LLC | 3 | $4,921 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $4,316 |
| Bristol Myers Squibb | 1 | $3,823 |
| Gilead | 2 | $3,310 |
| Celltrion Healthcare Co., Ltd | 1 | $500 |
| Ferring International Center SA | 1 | $207 |
| Abiomed | 2 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $12 |
How this compares
$2,420,311 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Ann Arbor
- Jeffery BerinsteinAnn Arbor$3.3M
- Frederick AskariAnn Arbor$1.4M
- Ryan StidhamAnn Arbor$656K
- Shanti EswaranAnn Arbor$575K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Anna LokAnn Arbor$434K
- Joan ChenAnn Arbor$409K
- Hari ConjeevaramAnn Arbor$352K
- Neehar ParikhAnn Arbor$351K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.